Board approves cBHT policy

Published December 11, 2020

The APC Board of Directors has approved the alliance’s official policy statement on compounded bio-identical hormone therapy.

Highlights of the statement:

  • APC opposes any additional regulation of cBHT.
  • APC supports all compounded hormone therapy, with no preference for particular dosage forms.
  • APC opposes restrictions that would limit hormone compounding to pharmacies that adhere to cGMP.

Click here to read the full statement, and visit for all our latest information on the fight to protect cBHT.